Javascript must be enabled to continue!
Mortality in Blind Subjects
View through CrossRef
<i>Background:</i> Previous studies indicated that mortality is increased in blind subjects. However, no detailed analysis with respect to causes of blindness and the effect of additional diseases has been performed. The present study was undertaken to examine these questions. <i>Materials and Methods:</i> The investigation is based on social security files from the Württemberg-Hohenzollern region (population 5.5 millions) in Germany. In total, 571 files of blind subjects whose blindness benefits terminated (mostly due to death) in 1994 were included. Medical opinions on ophthalmological status and general health were extracted from the files. Standardised mortality ratios (SMRs) on the basis of life tables of former West Germany were calculated using maximum likelihood methods taking into account censoring. <i>Results:</i> Most subjects in our study had one or more additional diseases at onset of blindness (74%). The SMR in all blind is 1.41 [95% CI (confidence interval) = 1.28–1.54; n= 571]. Mortality of blind subjects is increased if subjects suffer from multiple disease at onset of blindness: the SMR in blind with multiple diseases is 1.76 (95% CI = 1.58–1.94; n = 421) versus 0.85 (CI = 0.70–1.0; n = 150) in otherwise healthy blind subjects. In cases where specifically ocular diseases were responsible for the visual loss, the symbol [M] indicates that the blind subject suffered from multiple disease at onset of blindness and [E] denotes that this was not the case. The SMRs for main causes of blindness are: macular degeneration [M] 1.5 (CI = 1.3–1.8; n = 123), [E] 1.1 (CI = 0.8–1.5; n = 43); glaucoma [M] 1.6 (CI = 1.3–2.1; n = 65), [E] 1.0 (CI = 0.6–1.5; n = 26); high myopia [M] 1.2 (CI = 0.8–1.7; n = 32), [E] 0.8 (CI = 0.5–1.2; n = 21); optic atrophy [M] 1.1 (CI = 0.6–1.8; n = 19), [E] 1.4 (CI = 0.4–3.2; n = 4), and tapetoretinal degeneration [M] 2.3 (CI = 1.1– 4.2; n = 10), [E] 0.9 (CI = 0.4–1.8; n = 12). The SMR of cases of blindness in conjunction with other diseases was fairly high for diabetic retinopathy: 5.5 (CI = 4.4–6.8; n = 81). Central-nervous-system-triggered blindness led to an SMR of 1.5 (CI = 1.0–2.2; n = 37). <i>Discussion:</i> According to the results of the present study mortality is significantly increased in blind subjects. However, increased mortality in cases of blindness due to specifically ocular disease (e.g. macular degeneration) is associated with the presence of multiple (extra-ocular) diseases at onset of blindness.
Title: Mortality in Blind Subjects
Description:
<i>Background:</i> Previous studies indicated that mortality is increased in blind subjects.
However, no detailed analysis with respect to causes of blindness and the effect of additional diseases has been performed.
The present study was undertaken to examine these questions.
<i>Materials and Methods:</i> The investigation is based on social security files from the Württemberg-Hohenzollern region (population 5.
5 millions) in Germany.
In total, 571 files of blind subjects whose blindness benefits terminated (mostly due to death) in 1994 were included.
Medical opinions on ophthalmological status and general health were extracted from the files.
Standardised mortality ratios (SMRs) on the basis of life tables of former West Germany were calculated using maximum likelihood methods taking into account censoring.
<i>Results:</i> Most subjects in our study had one or more additional diseases at onset of blindness (74%).
The SMR in all blind is 1.
41 [95% CI (confidence interval) = 1.
28–1.
54; n= 571].
Mortality of blind subjects is increased if subjects suffer from multiple disease at onset of blindness: the SMR in blind with multiple diseases is 1.
76 (95% CI = 1.
58–1.
94; n = 421) versus 0.
85 (CI = 0.
70–1.
0; n = 150) in otherwise healthy blind subjects.
In cases where specifically ocular diseases were responsible for the visual loss, the symbol [M] indicates that the blind subject suffered from multiple disease at onset of blindness and [E] denotes that this was not the case.
The SMRs for main causes of blindness are: macular degeneration [M] 1.
5 (CI = 1.
3–1.
8; n = 123), [E] 1.
1 (CI = 0.
8–1.
5; n = 43); glaucoma [M] 1.
6 (CI = 1.
3–2.
1; n = 65), [E] 1.
0 (CI = 0.
6–1.
5; n = 26); high myopia [M] 1.
2 (CI = 0.
8–1.
7; n = 32), [E] 0.
8 (CI = 0.
5–1.
2; n = 21); optic atrophy [M] 1.
1 (CI = 0.
6–1.
8; n = 19), [E] 1.
4 (CI = 0.
4–3.
2; n = 4), and tapetoretinal degeneration [M] 2.
3 (CI = 1.
1– 4.
2; n = 10), [E] 0.
9 (CI = 0.
4–1.
8; n = 12).
The SMR of cases of blindness in conjunction with other diseases was fairly high for diabetic retinopathy: 5.
5 (CI = 4.
4–6.
8; n = 81).
Central-nervous-system-triggered blindness led to an SMR of 1.
5 (CI = 1.
0–2.
2; n = 37).
<i>Discussion:</i> According to the results of the present study mortality is significantly increased in blind subjects.
However, increased mortality in cases of blindness due to specifically ocular disease (e.
g.
macular degeneration) is associated with the presence of multiple (extra-ocular) diseases at onset of blindness.
Related Results
Line Blind Technology
Line Blind Technology
Abstract
Executive Summary
Line blind is a new positive isolation technology that may replace traditional blinding. Line blind r...
Serum Proinsulin in Bangladeshi Subjects with Impaired Glucose Tolerance
Serum Proinsulin in Bangladeshi Subjects with Impaired Glucose Tolerance
Hyperproinsulinemia is commonly present in subjects with impaired glucose tolerance. The present study was undertaken to investigate the proinsulin level in Bangladeshi IGT subject...
DFN‐02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double‐Blind, Placebo‐Controlled Study
DFN‐02 (Sumatriptan 10 mg With a Permeation Enhancer) Nasal Spray vs Placebo in the Acute Treatment of Migraine: A Double‐Blind, Placebo‐Controlled Study
Objective
The objective of this study was to evaluate the efficacy, safety, and tolerability of DFN‐02 — a nasal spray comprising sumatriptan 10 mg and a permea...
The design of an improved intelligent guide stick for the blind
The design of an improved intelligent guide stick for the blind
Abstract
There are about 17 million blind people in China, which means that one out of every 80 people is blind. However, due to the lack of facilities and policies ...
Evolution of infant mortality in Ukraine
Evolution of infant mortality in Ukraine
Over the past decades in Ukraine, the unfavorable indicators of population reproduction, the state of health of women and children, acquired in the previous period, have become per...
Wyniki badań 110 dziewcząt “nie uczących się i nie pracujących”
Wyniki badań 110 dziewcząt “nie uczących się i nie pracujących”
The publication presents the findings of an inquiry conducted among 110 girls aged 15 - 17 who had been directed, on the grounds of being “out of school and out of work”, to two on...
Experimental study on tensile behavior of blind bolt
Experimental study on tensile behavior of blind bolt
AbstractAs blind bolt can be installed only on one side, it has the advantage that ordinary high strength bolt doesn't have in the application of closed section connection. In this...
Correlation of COVID-19 Mortality with Clinical Parameters in an Urban and Suburban Nursing Home Population
Correlation of COVID-19 Mortality with Clinical Parameters in an Urban and Suburban Nursing Home Population
Abstract
Importance and Objective
COVID-19 has a high mortality rate amongst nursing home populations (26.4% nationally and 28....

